Hostile takeovers, activism, and defense basics

M&A guideAdvisory situations9 min read

Friendly versus unsolicited: where the line sits

The overwhelming majority of acquisitions are friendly: a buyer approaches a target's board directly, the board engages, and if terms are agreed, the board recommends the deal to shareholders. An unsolicited, or hostile, approach happens when a buyer tries to acquire a company after the board has rejected an approach, or without meaningfully engaging the board at all, going instead directly to shareholders. Most M&A interviews for a generalist seat never touch this territory in depth, but M&A-focused groups, and especially boutiques known for takeover defense work, expect you to know the basic vocabulary and logic, since it is a real, if less common, part of the mandate landscape covered in how M&A teams are organized.

It helps to think of the hostile process as a spectrum rather than a binary. A "bear hug" is a public letter from a would-be acquirer to a target's board, disclosing an offer and applying public pressure to engage, without yet taking the offer directly to shareholders; it is a step short of a full hostile approach, meant to force a reluctant board to the table through the pressure of public disclosure and shareholder expectation. If the board still refuses to engage, an acquirer can escalate to a tender offer, an offer made directly to shareholders to buy their shares at a stated price, bypassing the board entirely, or to a proxy fight, a campaign to replace enough of the target's board with directors sympathetic to the deal that the new board will approve it.

Tactics an acquirer uses

TacticWhat it isEffect
Bear hugPublic letter disclosing an offer and pressuring the board to engageApplies public and shareholder pressure without bypassing the board outright
Tender offerA direct offer to shareholders to buy their shares at a stated priceBypasses the board, appeals directly to shareholders' own financial interest
Proxy fightA campaign to elect a slate of directors sympathetic to the dealAims to replace the board itself rather than buy shares directly
Creeping acquisitionGradually buying shares in the open market toward a control stakeBuilds a position and influence before or instead of a formal offer

Each of these tactics has real limits. A tender offer's success depends on enough shareholders actually being willing to sell, which is harder if the target's shareholder base is concentrated among long-term holders who trust the board's judgment. A proxy fight requires winning enough votes at an actual shareholder meeting, a genuinely uncertain and expensive undertaking that can fail even when the acquirer's underlying financial case is sound, if shareholders simply prefer the incumbent board's strategy or distrust the acquirer's intentions.

Defensive tactics a target's board can deploy

A target board facing an unwanted approach has a range of defenses, most developed and refined through decades of case law, mainly in Delaware, that constrain how aggressively a board can resist without breaching its fiduciary duties.

The most well-known defense is the poison pill, formally a shareholder rights plan, which gives existing shareholders (other than the acquirer) the right to buy additional shares at a steep discount if any single party crosses a specified ownership threshold, typically diluting the acquirer's stake dramatically if triggered. A poison pill does not prevent an acquisition outright, boards can and do rescind or waive one to allow a deal they support, but it gives the board leverage and time, forcing a would-be acquirer to negotiate with the board rather than simply accumulating shares or launching a tender offer unopposed.

A staggered, or classified, board is a structural defense: instead of the entire board standing for election each year, only a fraction (often one-third) is up for election in any given year, meaning a proxy fight to replace a majority of the board can take more than one election cycle to succeed. This slows a hostile acquirer's ability to gain board control through a proxy fight alone, buying the incumbent board time to negotiate or find alternatives.

Other defenses include a white knight, a friendlier alternative acquirer the target's board solicits to compete with an unwanted bidder, effectively turning a hostile situation into a competitive process on the target's own terms, and golden parachutes, contractual severance packages for executives triggered by a change of control, which are sometimes criticized as enriching management at shareholders' expense but are also defended as removing management's personal incentive to resist a deal that would actually benefit shareholders. A defense used historically but now rare, partly due to tax and reputational consequences, is greenmail, where a target buys back an activist's or acquirer's stake at a premium simply to make them go away; this tactic has fallen out of favor and rarely appears in modern deals, though interviewers sometimes ask about it specifically to test whether you understand why it went out of fashion.

DefenseMechanismPrimary effect
Poison pill (shareholder rights plan)Dilutes any party crossing an ownership thresholdForces the acquirer to negotiate with the board rather than act unilaterally
Staggered boardOnly a fraction of directors face election each yearSlows a proxy fight's ability to gain board control
White knightBoard solicits a friendlier competing bidderConverts a hostile situation into a competitive process
Golden parachutesChange-of-control severance for executivesRemoves management's personal incentive to resist a beneficial deal

Shareholder activism: a different kind of pressure

Activist investors are a related but distinct force from a hostile acquirer. An activist typically buys a meaningful, though usually minority, stake in a public company and then publicly pushes for specific changes: a strategic review, a sale of the whole company or a division, a change in capital allocation (returning cash to shareholders rather than reinvesting it), operational changes, or board seats for the activist's own nominees. An activist is not usually trying to acquire the company itself; it is trying to force the existing board and management to make a change the activist believes will unlock value.

Companies facing activist pressure often engage an M&A bank specifically for advisory support: assessing whether the activist's specific proposal (a sale, a spin-off, a buyback) actually makes sense, preparing a defense of the current strategy if the board disagrees, and sometimes ultimately running the very sale or divestiture process the activist was pushing for, if the board concludes the activist has a point. This is one of the more common ways a defense mandate turns directly into a live sell-side or carve-out mandate, discussed further in carve-outs and divestitures.

A hypothetical shows how an activist campaign typically unfolds. Suppose an activist fund builds a five percent stake in a diversified industrial company and publicly argues that the company's slower-growing specialty division is depressing the stock's overall multiple, and that the board should explore a sale or spin-off of that division. The board, advised by an M&A bank, first evaluates the argument on its merits: does a sum-of-parts valuation actually support the activist's claim, and would a sale or spin-off realistically be executable given the division's standalone financial profile, a question that connects directly to the separation challenges covered in carve-outs and divestitures. If the analysis supports the activist's thesis, the board may choose to run the divestiture proactively, framing it as the board's own strategic decision rather than a concession to outside pressure, which is often the better outcome for both the company's reputation and the eventual sale process's leverage. If the board disagrees, it prepares a public defense of its current strategy, sometimes including its own third-party valuation analysis, and the fight can proceed to a proxy contest at the next annual meeting if the activist believes shareholders will side with it.

Board advisory work in a defense or activism situation also frequently intersects with the kind of independent evaluation covered in fairness opinions and board advisory work, particularly when a board facing pressure ultimately decides to run a sale process and needs an independent view on whether the resulting price is genuinely fair, not just a response to activist pressure.

How these situations actually resolve

Despite the aggressive vocabulary, most attempted hostile approaches and activist campaigns end in one of two ways rather than a prolonged fight to the finish. Many get negotiated into a friendly transaction once the target's board, having initially resisted, concludes that engaging on price and terms serves shareholders better than continued resistance, sometimes after a white knight process establishes that no better alternative actually exists. Others are abandoned by the acquirer or activist once it becomes clear the target's defenses, or its shareholder base's loyalty, make success unlikely without paying a price the acquirer is unwilling to meet.

Two historical situations are worth knowing by name, since interviewers reference them as shorthand for how differently these situations can resolve. Oracle's pursuit of PeopleSoft in the early 2000s is a well-known example of an unsolicited approach that succeeded after an extended fight, including a tender offer directly to shareholders and a lengthy antitrust review, and it is commonly referenced when discussing how persistence and regulatory patience can eventually overcome initial board resistance. Air Products' attempted hostile bid for Airgas, by contrast, ultimately failed after Airgas's board successfully used its poison pill and staggered board to run out the clock, and a Delaware court upheld the target board's right to maintain those defenses even against a price many shareholders reportedly found attractive, making it a standard reference for how strong structural defenses can allow a board to say no and make it stick, at least for a period.

Practice question

A target company's board has just rejected an unsolicited takeover offer. What options does the acquirer have, and what can the target's board do in response?

If the board rejects the approach outright, the acquirer's main options are to escalate publicly, sending a bear hug letter disclosing the offer to pressure the board through shareholders and public opinion, or to go further and take the offer directly to shareholders through a tender offer, or attempt a proxy fight to replace enough of the board with directors who would approve the deal. Each of those carries real execution risk. A tender offer only works if enough shareholders are willing to sell directly, and a proxy fight requires actually winning a shareholder vote, which isn't guaranteed even if the acquirer's financial case is sound. On the target's side, the board's main defenses are a poison pill, which dilutes the acquirer sharply if it crosses an ownership threshold and forces it to negotiate rather than just buy shares in the market, and, if the company has one, a staggered board, which slows down how quickly a proxy fight could actually hand the acquirer board control. The board can also go find a white knight, a friendlier alternative bidder, to create real competitive tension on its own terms rather than just saying no indefinitely. In practice, most of these situations end up getting negotiated into a friendly deal once both sides see how the numbers and the process are likely to play out, or the acquirer walks away if the target's defenses make success too costly.

What the interviewer is listening for: Whether you know the actual mechanics, not just the vocabulary, of both the offensive and defensive tools, and whether you understand that most hostile situations resolve through negotiation rather than a fight to the finish.

Practice this topic inside IB Atlas: spoken mock interviews graded by AI, built around exactly what interviewers ask.

Start free

More in M&A

Back to Breaking into M&A investment banking or the M&A investment banking interview questions.

Free question bank: 125 real interview questions with answers